苏州鑫康合生物医药科技有限公司

About 苏州鑫康合生物医药科技有限公司

Our company focuses on the research and development of antibody drugs for tumors, immunity, and inflammatory diseases. By developing drugs targeting novel targets or innovative combinations, we provide patients with highly precise, high-quality, and highly effective new treatments. The company's development vision is to become a world-class innovative immunotherapy pharmaceutical company. The company possesses world-class research and translational medicine capabilities, as well as rich R&D foundations and resources. X-Kang United Company was founded in Nov. 2015, the headquarters is based in BioBAY of Suzhou. X-Kang is a biopharmaceutical company to research innovative and effective antibody medicines for cancer and autoimmune diseases. X-Kang's core scientific team members have strong educational backgrounds and rich drug innovation experiences. We rooted in China with the global vision to discover and develop novel treatments for cancer and autoimmune diseases.